Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026)
Senseonics Holdings (SENS) posted quarterly Liabilities and Shareholders Equity of $102.9 million for Q1 2026, up 17.94% year-over-year from $87.2 million in Q1 2025, and down 18.54% quarter-over-quarter from $126.3 million in Q4 2025.
Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Liabilities and Shareholders Equity for 13 consecutive years, with $102.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 17.94% year-over-year to $102.9 million; the TTM figure through Mar 2026 stood at $519.3 million (up 31.29% YoY), while the FY2025 annual figure was $126.3 million, up 25.72% from the prior year.
- Liabilities and Shareholders Equity fell to $102.9 million in Q1 2026 per SENS's latest filing, from $126.3 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $188.1 million in Q1 2022 and bottomed at $87.2 million in Q1 2025.
- Historically, Liabilities and Shareholders Equity has averaged $139.4 million across 5 years, with a median of $139.9 million in 2025.
- Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity sank 37.47% — and 2025, when it surged 45.25%.
- Senseonics Holdings' Liabilities and Shareholders Equity stood at $177.7 million in 2022, then fell by 22.21% to $138.2 million in 2023, then fell by 27.33% to $100.4 million in 2024, then climbed by 25.72% to $126.3 million in 2025, then decreased by 18.54% to $102.9 million in 2026.
- Business Quant data shows SENS's Liabilities and Shareholders Equity at $102.9 million in Q1 2026, $126.3 million in Q4 2025, and $139.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Senseonics Holdings | 517.40 Mn | 276.80 Mn | 8.56 Mn | 176.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 176.84 Mn |
| Mar 31, 2026 | 102.86 Mn |
| Dec 31, 2025 | 126.27 Mn |
| Sep 30, 2025 | 139.92 Mn |
| Jun 30, 2025 | 150.27 Mn |
| Mar 31, 2025 | 87.21 Mn |
| Dec 31, 2024 | 100.44 Mn |
| Sep 30, 2024 | 96.33 Mn |
| Jun 30, 2024 | 111.56 Mn |
| Mar 31, 2024 | 126.52 Mn |
| Dec 31, 2023 | 138.22 Mn |
| Sep 30, 2023 | 154.07 Mn |
| Jun 30, 2023 | 153.36 Mn |
| Mar 31, 2023 | 158.53 Mn |
| Dec 31, 2022 | 177.67 Mn |
| Sep 30, 2022 | 182.67 Mn |
| Jun 30, 2022 | 175.33 Mn |
| Mar 31, 2022 | 188.10 Mn |
| Dec 31, 2021 | 198.93 Mn |
| Sep 30, 2021 | 219.62 Mn |